国内益生菌制剂在根除幽门螺杆菌治疗的现状  

Probiotic usage for improvement of Helicobacter pylori eradication in China

作　　者：金静怡[1] 张振玉[1] 

机构地区：[1]南京医科大学附属南京医院(南京市第一医院)消化科,江苏省南京市210006

出　　处：《世界华人消化杂志》2015年第18期2936-2941,共6页World Chinese Journal of Digestology

摘　　要：幽门螺杆菌(Helicobacter pylori,H.pylori)是引起消化性溃疡、慢性胃炎、胃癌以及胃黏膜相关淋巴组织(mucosal-associated lymphoid tissue,MALT)淋巴瘤等疾病的重要诱因,近年来使用传统三联疗法根除H.pylori的根除率逐年下降,为了提高H.pylori的根除率,提出了"以菌治菌"的治疗理念,本文主要就国内益生菌制剂提高H.pylori根除率的相关研究展开相应的讨论.Helicobacter pylori（H.pylori） causes many diseases,including peptic ulcer,chronic gastritis,gastric cancer and mucosal-associated lymphoid tissue lymphoma（MALT lymphoma）.In recent years,the eradication rate of H.pylori using traditional triple therapy has declined year by year.In order to improve the eradication rate of H.pylori,some scholars put forward the theory of ＂fighting bacteria with bacteria＂.This paper reviews the status of probiotic usage for improvement of H.pylori eradication in China.

关 键 词：益生菌 幽门螺杆菌 临床应用 

分 类 号：R57[医药卫生—消化系统]